Clinical-stage cell therapy company, Chimeric Therapeutics has snapped up a US patent for its cancer fighting CLTX CAR therapies. According to Chimeric the United States represents the single largest global market for biopharmaceutical products and the patent will add further protection to its burgeoning roster of intellectual property. The move follows a recent patent grant for the technology…
